Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -CN¥71 | CN¥1,279 | CN¥3,810 | CN¥3,031 |
| Dep. & Amort. | CN¥992 | CN¥1,002 | CN¥930 | CN¥644 |
| Deferred Tax | CN¥0 | CN¥0 | -CN¥28 | CN¥98 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥506 | CN¥0 |
| Change in WC | -CN¥614 | -CN¥2,203 | -CN¥2,178 | -CN¥544 |
| Other Non-Cash | CN¥160 | CN¥122 | -CN¥396 | CN¥65 |
| Operating Cash Flow | CN¥468 | CN¥80 | CN¥2,644 | CN¥3,197 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥1,116 | -CN¥829 | -CN¥936 | -CN¥1,735 |
| Net Acquisitions | CN¥0 | CN¥91 | CN¥4 | CN¥18 |
| Inv. Purchases | -CN¥284 | -CN¥165 | CN¥0 | -CN¥57 |
| Inv. Sales/Matur. | CN¥29 | CN¥120 | CN¥62 | CN¥52 |
| Other Inv. Act. | -CN¥16 | -CN¥120 | CN¥63 | CN¥0 |
| Investing Cash Flow | -CN¥1,387 | -CN¥903 | -CN¥807 | -CN¥1,722 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥6,490 | CN¥147 | CN¥459 | -CN¥808 |
| Stock Issued | -CN¥1 | CN¥0 | CN¥669 | CN¥180 |
| Stock Repurch. | -CN¥1,197 | -CN¥500 | -CN¥669 | -CN¥180 |
| Dividends Paid | -CN¥247 | -CN¥464 | -CN¥198 | -CN¥78 |
| Other Fin. Act. | -CN¥198 | -CN¥198 | CN¥744 | CN¥447 |
| Financing Cash Flow | CN¥4,847 | -CN¥944 | CN¥1,005 | -CN¥619 |
| Forex Effect | CN¥19 | CN¥5 | CN¥22 | -CN¥11 |
| Net Chg. in Cash | CN¥3,947 | -CN¥1,640 | CN¥2,864 | CN¥844 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥2,905 | CN¥4,545 | CN¥1,681 | CN¥837 |
| End Cash | CN¥6,852 | CN¥2,905 | CN¥4,545 | CN¥1,681 |
| Free Cash Flow | -CN¥648 | -CN¥748 | CN¥1,708 | CN¥1,462 |